Cite
Misra S, Ghatak S, Vyas A, et al. Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer. Med Chem Res. 2014;23(8):3836-3851doi: 10.1007/s00044-014-0958-4.
Misra, S., Ghatak, S., Vyas, A., O'Brien, P., Markwald, R. R., Khetmalas, M., Hascall, V. C., McCarthy, J. B., Karamanos, N. K., Tammi, M. I., Tammi, R. H., Prestwitch, G. D., & Padhye, S. (2014). Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 23(8), 3836-3851. https://doi.org/10.1007/s00044-014-0958-4
Misra, Suniti, et al. "Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer." Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents vol. 23,8 (2014): 3836-3851. doi: https://doi.org/10.1007/s00044-014-0958-4
Misra S, Ghatak S, Vyas A, O'Brien P, Markwald RR, Khetmalas M, Hascall VC, McCarthy JB, Karamanos NK, Tammi MI, Tammi RH, Prestwitch GD, Padhye S. Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer. Med Chem Res. 2014 Aug 01;23(8):3836-3851. doi: 10.1007/s00044-014-0958-4. PMID: 25013352; PMCID: PMC4084864.
Copy
Download .nbib